A detailed history of Ever Source Wealth Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 110 shares of BNTX stock, worth $12,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 483 77.23%
Holding current value
$12,554
Previous $38,000 65.79%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$78.36 - $124.66 $29,228 - $46,498
-373 Reduced 77.23%
110 $13,000
Q2 2024

Aug 13, 2024

SELL
$80.36 - $102.87 $482 - $617
-6 Reduced 1.23%
483 $38,000
Q1 2024

Jun 11, 2024

BUY
$88.96 - $112.35 $22,417 - $28,312
252 Added 106.33%
489 $45,000
Q4 2023

Feb 09, 2024

SELL
$90.91 - $112.75 $56,182 - $69,679
-618 Reduced 72.28%
237 $25,000
Q3 2023

Nov 03, 2023

BUY
$98.5 - $125.08 $54,766 - $69,544
556 Added 185.95%
855 $92,000
Q2 2023

Aug 04, 2023

BUY
$102.58 - $129.66 $11,694 - $14,781
114 Added 61.62%
299 $32,000
Q1 2023

May 11, 2023

SELL
$122.57 - $153.67 $24,881 - $31,195
-203 Reduced 52.32%
185 $23,000
Q4 2022

Feb 09, 2023

BUY
$118.43 - $186.05 $45,950 - $72,187
388 New
388 $58,000
Q2 2022

Aug 01, 2022

BUY
$123.25 - $186.24 $44,370 - $67,046
360 New
360 $54,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.